The medical world is witnessing a remarkable shift in blood sugar therapy with the arrival of GLP-1 transdermal devices. These systems offer a potentially more user-friendly alternative to shots of GLP-1 receptor agonists, reducing the requirement of daily needle pokes. The approach releases the medication directly through the surface, arguably enh